Patents Assigned to Genase Therapeutics B.V.
  • Tetrahydroindazoles and medical uses thereof
    Patent number: 10889564
    Abstract: There is herein provided a compound of formula I (I) or a pharmaceutically acceptable salt thereof, for use in the treatment of cancer and/or the treatment or prevention of a viral infection, wherein A1, A2, L1, R1, R2 and n have meanings as provided in the description.
    Type: Grant
    Filed: November 1, 2016
    Date of Patent: January 12, 2021
    Assignee: Genase Therapeutics B.V.
    Inventors: Sonia Lain, Catherine Drummond, Ingeborg Van Leeuwen, Martin Haraldsson, Lars Johansson, Lars Sandberg, Ulrika Yngve